Julie Russo • June 4, 2025
Legislative Advocacy Updates June 2025

Nevada Adopts Component of Children's Cardiac Safety Bill introduced by HCMA Legislative Advocate Jane Grossman

Nevada HCMA Legislative State Champion Jane Grossman helped introduce an essential component of the Children's Cardiac Safety Act into another related bill, a broad-ranging health bill. Rather than introducing a separate bill, Assemblymember David Orentlicher thought he would have a better chance of passing this legislation by combining it with other changes for medical providers (Nevada AB 319).


Thanks to Jane's efforts, each time an osteopathic physician or physician assistant performs a routine physical examination of a person aged at least 12 but not more than 18, the physician or physician assistant shall ask the person the questions prescribed in the Medical History Form and the Physical Examination Form of the Preparticipation Physical Evaluation Form developed jointly by the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Sports Medicine, the American Medical Society for Sports Medicine, the American Orthopedic Society for Sports Medicine, and the American Osteopathic Academy of Sports Medicine, or any successor form.


Nevada's AB 319 was unanimously passed by both the lower house and the Senate and awaits the governor's signature to become law. Jane said, "The key to passing the Children's Cardiac Safety Act is making strong connections with your legislators and presenting it clearly. I also met with the Director of the State Board of Medical Examiners, a pivotal connection for desired changes for medical practitioners. Although I would have preferred a single bill for this important act, it was more strategic to follow Assemblymember Orentlicher's lead to add it to a larger bill. It was also helpful to provide meaningful testimony, and I testified along with the mother of a child with HCM."

Congratulations, Jane!

HCMA Blog

By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
A light blue and dark blue paintbrush stroke intersect to make a stylized
By Erica Friedman June 18, 2025
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
Light & dark blue brush stroke that intersect create an abstract letter 'a' next to the word Alnylam
By Erica Friedman June 17, 2025
AMVUTTRA® (vutrisiran) has been approved by the U.S. Food and Drug Administration (FDA) to treat ATTR-CM in adults.
More Posts